Pharmaceutical Executive May 16, 2022
The second of two parts of Pharmaceutical Executive’s Q&A discussion with Vinod Badami, Vice President, Data and Analytics at Indegene.
Pharmaceutical Executive: Does social listening provide real-world evidence (RWE) for drug development?
Vinod Badami: As mentioned earlier, HCPs are starting to get more comfortable with discussing medical-related information on social media. They evaluate the safety and efficacy of treatments through debates and discussions, promote new drug discoveries, and so on.
Similarly, patients have also taken to online review platforms or discussion forums to share their personal experiences, challenges, and side effects using specific treatments.
As a result, there is massive amount of information (albeit unstructured) that pharmaceutical organizations can leverage in addition to the structured RWE sources (like claims...